Related Experiment Video
Updated: May 28, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
miR-214 Promotes Aggressive Behavior in Triple-Negative Breast Cancer by Functionally Targeting the 3'-UTR of FRK
Serin Moon1, Sooeun Oh1, Dong-Min Kim1
1Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Abstract:
Background/Objectives: MicroRNAs (miRNAs) are key regulators of gene expression and have been implicated in multiple aspects of cancer progression. However, the role of miR-214-3p in breast cancer remains controversial. In this study, we investigated the functional role of miR-214-3p and explored its potential regulatory target in breast cancer, particularly in triple-negative breast cancer (TNBC). Methods: miR-214-3p expression was evaluated in breast cancer cell lines. Luciferase reporter assays were performed to assess functional targeting of the FRK 3'-UTR. Functional assays, including proliferation, migration, and invasion assays, were conducted following miR-214-3p overexpression or FRK silencing. Results: miR-214-3p was markedly upregulated in TNBC cells (MDA-MB-231), while Fyn-related kinase (FRK), a potential tumor suppressor, showed an inverse expression trend. Luciferase reporter assays demonstrated that miR-214-3p functionally targets the 3'-UTR of FRK. Functional analyses revealed that overexpression of miR-214-3p significantly increased cell proliferation, migration, and invasion. Notably, silencing of FRK recapitulated these effects, supporting its role as a functional mediator of miR-214-3p. Conclusions: This study identifies a miR-214-FRK regulatory axis in breast cancer and suggests its contribution to aggressive tumor behavior. Targeting miR-214-3p or modulating FRK activity may represent a potential therapeutic strategy.
Insights
MicroRNA-214-3p (miR-214-3p) promotes aggressive breast cancer by targeting the tumor suppressor Fyn-related kinase (FRK). This miR-214-FRK axis offers potential therapeutic targets for triple-negative breast cancer (TNBC).
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- MicroRNAs (miRNAs) are crucial gene regulators in cancer progression.
- The specific role of miR-214-3p in breast cancer, especially triple-negative breast cancer (TNBC), is debated.
- Understanding miRNA functions is vital for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the functional role of miR-214-3p in breast cancer.
- To identify and validate the regulatory target of miR-214-3p.
- To explore the therapeutic potential of targeting miR-214-3p or its target in TNBC.
Main Methods:
- Expression analysis of miR-214-3p in breast cancer cell lines.
- Luciferase reporter assays to confirm miR-214-3p targeting of Fyn-related kinase (FRK) 3'-UTR.
- Functional assays (proliferation, migration, invasion) upon miR-214-3p overexpression or FRK silencing.
Main Results:
- miR-214-3p was significantly upregulated in TNBC cells, inversely correlating with FRK expression.
- miR-214-3p directly targets and represses FRK.
- Overexpression of miR-214-3p enhanced cell proliferation, migration, and invasion, effects mimicked by FRK silencing.
Conclusions:
- A novel regulatory axis between miR-214-3p and FRK was identified in breast cancer.
- This axis contributes to aggressive tumor phenotypes, particularly in TNBC.
- Modulating miR-214-3p or FRK presents a promising therapeutic avenue for breast cancer treatment.
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

